ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT) (2010)
- Authors:
- USP affiliated authors: FEDERICO, MIRIAM HATSUE HONDA - FM ; PASINI, FÁTIMA SOLANGE - FM ; FERRAZ, ALBERTO ROSSETTI - FM
- Unidade: FM
- Subjects: POLIMORFISMO; NEOPLASIAS DE CABEÇA E PESCOÇO; QUIMIOTERÁPICOS; PESCOÇO (GENÉTICA)
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2010
- Source:
- Título: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 28, n. 15S , p. 431s, res. 5540, 2010
- Conference titles: Annual Meeting of the American Society of Clinical Oncology
-
ABNT
CASTRO, G. et al. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540. Acesso em: 10 jan. 2026. , 2010 -
APA
Castro, G., Pasini, F. S., Siqueira, S. A., Ferraz, A. R., Villar, R. C., Snitcovsky, I. M., & Federico, M. H. (2010). ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540 -
NLM
Castro G, Pasini FS, Siqueira SA, Ferraz AR, Villar RC, Snitcovsky IM, Federico MH. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT) [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 431s.[citado 2026 jan. 10 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540 -
Vancouver
Castro G, Pasini FS, Siqueira SA, Ferraz AR, Villar RC, Snitcovsky IM, Federico MH. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT) [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 431s.[citado 2026 jan. 10 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540 - ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation
- Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT)
- HMGCR MRNA expression in tongue squamous cell carcinoma
- Gene expression pattern of primary oral cancer is predictive of cervical lymph node metastases
- Determination of plasma osteopontin levels in patients with head and neck squamous cell carcinoma
- Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients
- New possible predictive marker of survival in oral squamous cell carcinoma
- Avaliação prospectiva de polimorfismo genéticos da glutationa-s-transferase P1 como fator prognóstico e preditivo de resposta em pacientes portadores de carcinoma epidermóide de cabeça e pescoço tratados com quimiorradioterapia
- Expression of CXCR1 and 'CX IND. 3'CR1 mRNA seems to outocome of the larynx squamous cell carcinoma
- Association of smads and TGFß mRNA expression with survival of oral squamous cell carcinoma patients
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
